Publications by authors named "Michael D Tarantino"

Claim this Profile
S
Safety, efficacy, and treatment satisfaction in adults with ITP who switched to avatrombopag from another TPO-RA.
Michael D Tarantino, Kailash Mosalpuria, Scott Kolodny, Jessica Zhang, Michael Vredenburg

Blood Adv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study.
Nichola Cooper, A J Gerard Jansen, Robert Bird, Jiří Mayer, Michelle Sholzberg, Michael D Tarantino

Am J Hematol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hereditary antithrombin deficiency pilot project registry from the American Thrombosis and Hemostasis Network.
Maria T DeSancho, Erin Suvar, Jonathan C Roberts, Michael D Tarantino, Jonathan Schwartz

J Thromb Haemost· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved prevention of bleeding episodes with emicizumab in 3 patients with concomitant hemophilia A and von Willebrand disease.
Kristin T Ansteatt, Jonathan C Roberts, Jackie M Helms, Michael D Tarantino

Blood Coagul Fibrinolysis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical challenges associated with efanesoctocog alfa (ALTUVIIIO) prophylaxis in a 19-month-old male with severe hemophilia A.
Jessica N Mistretta, Maria G Español, Michael D Tarantino, Dane C Christ, Maureen D Jones

Pediatr Blood Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Evolution of Hemophilia Therapeutics: An Illustrated Review.
María G Español, Jessica N Mistretta, Michael D Tarantino, Jonathan C Roberts

Res Pract Thromb Haemost· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Von Willebrand Factor (VWF) multiplex activity assay differentiation of type 1 von Willebrand Disease (VWD) and variant VWD.
Jonathan C Roberts, Pamela A Christopherson, Michael D Tarantino, Sarah E Gonzales, Patti A Morateck

Haemophilia· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy of simoctocog alfa versus extended half-life recombinant FVIII concentrates in hemophilia A patients undergoing personalized prophylaxis using a matching-adjusted indirect comparison method.
Craig M Kessler, Fernando F Corrales-Medina, Pier Mannuccio Mannucci, Víctor Jiménez-Yuste, Michael D Tarantino

Eur J Haematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rilzabrutinib placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study.
David J Kuter, James B Bussel, Waleed Ghanima, Nichola Cooper, Terry Gernsheimer, Michael D Tarantino

Ther Adv Hematol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world safety and effectiveness of recombinant porcine sequence factor VIII in acquired haemophilia A: A non-interventional, post-authorization safety study.
Michael D Tarantino, Brandon Hardesty, Ara Metjian, Thomas L Ortel, Jie Chen

Haemophilia· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma gastric biomarker evaluation with avatrombopag dosing in patients with chronic immune thrombocytopenia in phase 3 trials.
James B Bussel, Michael D Tarantino, Eun-Ju Lee, Brian D Jamieson

Br J Haematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3, randomized, double-blind, active-controlled trial evaluating efficacy and safety of avatrombopag versus eltrombopag in ITP.
Michael D Tarantino, James B Bussel, Eun-Ju Lee, Brian D Jamieson

Br J Haematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five Challenging Cases of Hereditary Antithrombin Deficiency Characterized by Thrombosis or Complicated Pregnancy.
Jonathan C Roberts, Annette von Drygalski, Jenny Y Zhou, George M Rodgers, Kristin Ansteatt, Michael D Tarantino

J Blood Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of laboratory coagulation parameters and risk factors for intraventricular hemorrhage in extremely premature neonates.
Jonathan C Roberts, M Jawad Javed, Molly K Lundy, Rita M Burns, Huaping Wang, Michael D Tarantino

J Thromb Haemost· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life in a large multinational haemophilia B cohort (The B-Natural study) - Unmet needs remain.
Erik Berntorp, Petra LeBeau, Margaret V Ragni, Munira Borhany, Yasmina L Abajas, Michael D Tarantino

Haemophilia· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP.
Eun-Ju Lee, Marina Beltrami-Moreira, Hanny Al-Samkari, Adam Cuker, Jennifer DiRaimo, Michael D Tarantino

Blood· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eculizumab for refractory thrombosis in antiphospholipid syndrome.
Habiba Hussain, Michael D Tarantino, Shruti Chaturvedi, Keith R McCrae, Jonathan C Roberts

Blood Adv· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time is Blood: The Impact of Diagnostic Delays on Acquired Hemophilia A.
Michael Fragner, Bailey Imbo, Jared Hobson, Jonathan C Roberts, Anita Rajasekhar, Michael D Tarantino

Cureus· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of romiplostim immunogenicity in pediatric patients in clinical trials and in a global postmarketing registry.
Charles Bowers, Daniel T Mytych, Tatiana Lawrence, Kejia Wang, Troy E Barger, Michael D Tarantino

Blood Adv· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case Report of COVID-Associated Catastrophic Antiphospholipid Syndrome Successfully Treated with Eculizumab.
Anusha Chidharla, Salman B Syed, Tulika Chatterjee, Michael D Tarantino

J Blood Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical overview and practical considerations for optimizing romiplostim therapy in patients with immune thrombocytopenia.
David J Kuter, Michael D Tarantino, Tatiana Lawrence

Blood Rev· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occurrence and management of severe bleeding episodes in patients with hereditary factor X deficiency.
Michael D Tarantino

Haemophilia· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination.
Eun-Ju Lee, Douglas B Cines, Terry Gernsheimer, Craig Kessler, Marc Michel, Michael D Tarantino

Am J Hematol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine.
Jackie M Helms, Kristin T Ansteatt, Jonathan C Roberts, Sravani Kamatam, Kap Sum Foong, Michael D Tarantino

J Blood Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of rFVIIIFc versus Emicizumab for the Treatment of Patients with Hemophilia A without Inhibitors: Matching-Adjusted Indirect Comparison of A-LONG and HAVEN Trials.
Robert Klamroth, Piotr Wojciechowski, Samuel Aballéa, Françoise Diamand, Zalmai Hakimi, Michael D Tarantino

J Blood Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis